Section Arrow
BDSX.NASDAQ
- Biodesix Inc
Quotes are at least 15-min delayed:2026/02/12 08:06 EST
Pre Market
Last
 10.34
-0.01 (-0.10%)
Bid
8.52
Ask
10.43
High 10.35 
Low 10.34 
Volume 101 
Regular Hours (Closed)
Last
 10.35
-0.05 (-0.48%)
Day High 
10.5753 
Prev. Close
10.4 
1-M High
12.7 
Volume 
86.86K 
Bid
8.52
Ask
10.43
Day Low
9.9 
Open
10.4 
1-M Low
6.9401 
Market Cap 
82.74M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.25 
20-SMA 10.05 
50-SMA 8.35 
52-W High 20.4 
52-W Low 3.436 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.23/-1.64
Enterprise Value
143.98M
Balance Sheet
Book Value Per Share
-0.22
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
71.32M
Operating Revenue Per Share
5.53
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IQVIQVIA Holdings177.18-5.27-2.89%24.37PE
Pre Market 165 -12.18 -6.87%
DHRDanaher Corp219.98+0.23+0.10%45.39PE
Pre Market 219.61 -0.37 -0.17%
WATWaters Corp329.2+2.18+0.67%30.26PE
Pre Market 331.555 +2.355 +0.72%
NEOGNeogen Corp10.75+0.02+0.19%-- 
Pre Market 10.66 -0.09 -0.84%
ICLRICON plc133.14-11.41-7.89%17.94PE
Pre Market 93.15 -39.99 -30.04%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.